Stonebridge Financial Planning Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Stonebridge Financial Planning Group's LLY Position: Q1 2026 in Review
Stonebridge Financial Planning Group reduced its Eli Lilly (LLY) stake by 1.5% in Q1 2026, selling an estimated $24.3K and leaving 1,589 shares worth $1.46M. The position accounts for 0.54% of the portfolio, ranked #61.
Stonebridge Financial Planning Group first reported a position in LLY in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.73M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Stonebridge Financial Planning Group held 1,589 shares of Eli Lilly worth $1.46M as of Q1 2026.
- Stonebridge Financial Planning Group sold 24 Eli Lilly shares in Q1 2026, an estimated $24.3K.
- Eli Lilly made up 0.54% of Stonebridge Financial Planning Group's portfolio in Q1 2026, its #61 holding.
- Stonebridge Financial Planning Group first reported a position in Eli Lilly in Q4 2019 and has held it in 20 quarters since.
- Stonebridge Financial Planning Group's Eli Lilly position peaked at $1.73M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Stonebridge Financial Planning Group's 13F filing for Q1 2026, filed 8 May 2026.